These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16702810)

  • 1. Thioredoxin reductase and cancer cell growth inhibition by organogold(III) compounds.
    Engman L; McNaughton M; Gajewska M; Kumar S; Birmingham A; Powis G
    Anticancer Drugs; 2006 Jun; 17(5):539-44. PubMed ID: 16702810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thioredoxin reductase and cancer cell growth inhibition by organotellurium antioxidants.
    Engman L; Al-Maharik N; McNaughton M; Birmingham A; Powis G
    Anticancer Drugs; 2003 Feb; 14(2):153-61. PubMed ID: 12569302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gold(III)-dithiocarbamato complexes induce cancer cell death triggered by thioredoxin redox system inhibition and activation of ERK pathway.
    Saggioro D; Rigobello MP; Paloschi L; Folda A; Moggach SA; Parsons S; Ronconi L; Fregona D; Bindoli A
    Chem Biol; 2007 Oct; 14(10):1128-39. PubMed ID: 17961825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase.
    Gandin V; Fernandes AP; Rigobello MP; Dani B; Sorrentino F; Tisato F; Björnstedt M; Bindoli A; Sturaro A; Rella R; Marzano C
    Biochem Pharmacol; 2010 Jan; 79(2):90-101. PubMed ID: 19665452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gold(III) bis(thiosemicarbazonate) compounds in breast cancer cells: Cytotoxicity and thioredoxin reductase targeting.
    Rodríguez-Fanjul V; López-Torres E; Mendiola MA; Pizarro AM
    Eur J Med Chem; 2018 Mar; 148():372-383. PubMed ID: 29471123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NHC gold halide complexes derived from 4,5-diarylimidazoles: synthesis, structural analysis, and pharmacological investigations as potential antitumor agents.
    Liu W; Bensdorf K; Proetto M; Abram U; Hagenbach A; Gust R
    J Med Chem; 2011 Dec; 54(24):8605-15. PubMed ID: 22091836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applying the designed multiple ligands approach to inhibit dihydrofolate reductase and thioredoxin reductase for anti-proliferative activity.
    Ng HL; Chen S; Chew EH; Chui WK
    Eur J Med Chem; 2016 Jun; 115():63-74. PubMed ID: 26994844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sublethal concentrations of diverse gold compounds inhibit mammalian cytosolic thioredoxin reductase (TrxR1).
    Omata Y; Folan M; Shaw M; Messer RL; Lockwood PE; Hobbs D; Bouillaguet S; Sano H; Lewis JB; Wataha JC
    Toxicol In Vitro; 2006 Sep; 20(6):882-90. PubMed ID: 16510263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and characterization of azolate gold(I) phosphane complexes as thioredoxin reductase inhibiting antitumor agents.
    Galassi R; Burini A; Ricci S; Pellei M; Rigobello MP; Citta A; Dolmella A; Gandin V; Marzano C
    Dalton Trans; 2012 May; 41(17):5307-18. PubMed ID: 22391922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Mammalian thioredoxin reductase by some flavonoids: implications for myricetin and quercetin anticancer activity.
    Lu J; Papp LV; Fang J; Rodriguez-Nieto S; Zhivotovsky B; Holmgren A
    Cancer Res; 2006 Apr; 66(8):4410-8. PubMed ID: 16618767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Undressing of phosphine gold(I) complexes as irreversible inhibitors of human disulfide reductases.
    Urig S; Fritz-Wolf K; Réau R; Herold-Mende C; Tóth K; Davioud-Charvet E; Becker K
    Angew Chem Int Ed Engl; 2006 Mar; 45(12):1881-6. PubMed ID: 16493712
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytotoxic and radiosensitising effects of a novel thioredoxin reductase inhibitor in breast cancer.
    Abdullah NA; Inman M; Moody CJ; Storr SJ; Martin SG
    Invest New Drugs; 2021 Oct; 39(5):1232-1241. PubMed ID: 33768386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New cyclometalated gold (III) complex targeting thioredoxin reductase: exploring as cytotoxic agents and mechanistic insights.
    Abyar F; Tabrizi L
    Biometals; 2020 Jun; 33(2-3):107-122. PubMed ID: 32246384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the C^N^C theme: Synthesis and biological properties of tridentate cyclometalated gold(III) complexes.
    Jürgens S; Scalcon V; Estrada-Ortiz N; Folda A; Tonolo F; Jandl C; Browne DL; Rigobello MP; Kühn FE; Casini A
    Bioorg Med Chem; 2017 Oct; 25(20):5452-5460. PubMed ID: 28823538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EM23, a natural sesquiterpene lactone, targets thioredoxin reductase to activate JNK and cell death pathways in human cervical cancer cells.
    Shao FY; Wang S; Li HY; Chen WB; Wang GC; Ma DL; Wong NS; Xiao H; Liu QY; Zhou GX; Li YL; Li MM; Wang YF; Liu Z
    Oncotarget; 2016 Feb; 7(6):6790-808. PubMed ID: 26758418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diaryl chalcogenides as selective inhibitors of thioredoxin reductase and potential antitumor agents.
    Engman L; Cotgreave I; Angulo M; Taylor CW; Paine-Murrieta GD; Powis G
    Anticancer Res; 1997; 17(6D):4599-605. PubMed ID: 9494575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticancer activity of a Gold(I) phosphine thioredoxin reductase inhibitor in multiple myeloma.
    Sze JH; Raninga PV; Nakamura K; Casey M; Khanna KK; Berners-Price SJ; Di Trapani G; Tonissen KF
    Redox Biol; 2020 Jan; 28():101310. PubMed ID: 31514052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiproliferative activity exerted by tricyclohexylphosphanegold(I) n-mercaptobenzoate against MCF-7 and A2780 cell lines: the role of p53 signaling pathways.
    Ang KP; Chan PF; Hamid RA
    Biometals; 2021 Feb; 34(1):141-160. PubMed ID: 33196940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gold(I) complexes of water-soluble diphos-type ligands: synthesis, anticancer activity, apoptosis and thioredoxin reductase inhibition.
    Wetzel C; Kunz PC; Kassack MU; Hamacher A; Böhler P; Watjen W; Ott I; Rubbiani R; Spingler B
    Dalton Trans; 2011 Sep; 40(36):9212-20. PubMed ID: 21826354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of the antitumoral activity of phosphine-thiosemicarbazone gold(I) complexes obtained by different methodologies.
    González-Barcia LM; Fernández-Fariña S; Rodríguez-Silva L; Bermejo MR; González-Noya AM; Pedrido R
    J Inorg Biochem; 2020 Feb; 203():110931. PubMed ID: 31786438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.